[{"bbox": [91, 99, 367, 130], "category": "Page-header", "text": "Q-Line Biotech Limited"}, {"bbox": [616, 170, 1035, 199], "category": "Section-header", "text": "# SECTION-IV – INTRODUCTION"}, {"bbox": [750, 234, 898, 262], "category": "Section-header", "text": "## THE ISSUE"}, {"bbox": [91, 294, 1556, 1979], "category": "Table", "text": "<table><thead><tr><th colspan=\"2\">PRESENT ISSUE IN TERMS OF THIS DRAFT RED HERRING PROSPECTUS</th></tr></thead><tbody><tr><td>Equity Shares Offered through Public Issue<sup>(1)(2)(3)</sup></td><td>Issue of upto 70,53,200* Equity Shares of ₹10 each for cash at a price of ₹ [●] (including a Share premium of ₹ [●] per Equity Share) per share aggregating to ₹ [●] Lakhs.</td></tr><tr><td colspan=\"2\"><strong>Out of which:</strong></td></tr><tr><td>Issue Reserved for the Market Maker</td><td>Upto [●] Equity Shares of ₹10 each for cash at a price of ₹ [●] (including a Share premium of ₹ [●] per Equity Share) per share aggregating to ₹ [●] Lakhs</td></tr><tr><td>Net Issue to the Public</td><td>Upto [●] Equity Shares of ₹10 each for cash at a price of ₹ [●] (including a Share premium of ₹ [●] per Equity Share) per share aggregating to ₹ [●] Lakhs</td></tr><tr><td colspan=\"2\"><strong>Out of which*</strong></td></tr><tr><td>A. QIB Portion<sup>(4)(5)</sup></td><td>Not more than [●] Equity Shares of ₹10 each for cash at a price of ₹ [●] (including a Share premium of ₹ [●] per Equity Share) per share aggregating to ₹ [●] Lakhs</td></tr><tr><td colspan=\"2\"><strong>Of which</strong></td></tr><tr><td>i) Anchor Investor Portion</td><td>Upto [●] Equity Shares of ₹10 each for cash at a price of ₹ [●] (including a Share premium of ₹ [●] per Equity Share) per share aggregating to ₹ [●] Lakhs</td></tr><tr><td>ii) Net QIB Portion (assuming Anchor Investor Portion is fully subscribed)</td><td>Upto [●] Equity Shares of ₹10 each for cash at a price of ₹ [●] (including a Share premium of ₹ [●] per Equity Share) per share aggregating to ₹ [●] Lakhs</td></tr><tr><td colspan=\"2\"><strong>Out Of which</strong></td></tr><tr><td>(a) Available for allocation to Mutual Funds only (5% of the Net QIB Portion)</td><td>Upto [●] Equity Shares of ₹10 each for cash at a price of ₹ [●] (including a Share premium of ₹ [●] per Equity Share) per share aggregating to ₹ [●] Lakhs</td></tr><tr><td>(b) Balance of QIB Portion for all QIBs including Mutual Funds</td><td>Upto [●] Equity Shares of ₹10 each for cash at a price of ₹ [●] (including a Share premium of ₹ [●] per Equity Share) per share aggregating to ₹ [●] Lakhs</td></tr><tr><td>B. Non-Institutional Portion</td><td>Not less than [●] Equity Shares of ₹10 each for cash at a price of ₹ [●] (including a Share premium of ₹ [●] per Equity Share) per share aggregating to ₹ [●] Lakhs</td></tr><tr><td colspan=\"2\"><strong>Of which</strong></td></tr><tr><td>One-third of the Non-Institutional Portion available for allocation to Bidders with an application size of more than two lots and up to such lots equivalent to not more than ₹ 10 lakhs</td><td>Upto [●] Equity Shares having face value of ₹10/- each at an Offer Price of ₹[●] per Equity Share (including a share premium of ₹[●] per Equity Share) aggregating to ₹ [●] Lakhs</td></tr><tr><td>Two-third of the Non-Institutional Portion available for allocation to Bidders with an application size of more than ₹ 10 lakhs</td><td>Upto [●] Equity Shares having face value of ₹10/- each at an Offer Price of ₹[●] per Equity Share (including a share premium of ₹[●] per Equity Share) aggregating to ₹ [●] Lakhs</td></tr><tr><td>C. Individual Investor Portion</td><td>Not less than [●] Equity Shares of ₹ 10 each for cash at a price of ₹ [●] (including a Share premium of ₹ [●] per Equity Share) per share aggregating to ₹ [●] Lakhs</td></tr><tr><td colspan=\"2\"><strong>Pre and Post – Issue Equity Shares</strong></td></tr><tr><td>Equity Shares outstanding prior to the Issue</td><td>1,62,74,999 Equity Shares of face value of Rs.10 each.</td></tr><tr><td>Equity Shares outstanding after the Issue</td><td>Upto [●] Equity Shares of face value Rs.10 each.</td></tr><tr><td>Use of Net Proceeds by our Company</td><td>Please see the chapter titled \"Objects of the Issue\" on page 86 of this Draft Red Herring Prospectus.</td></tr></tbody></table>"}, {"bbox": [91, 1981, 1558, 2044], "category": "Text", "text": "*Subject to finalisation of the Basis of Allotment, Number of shares may need to be adjusted for lot size upon determination of issue price."}, {"bbox": [91, 2076, 1558, 2141], "category": "Text", "text": "(1) Public issue of upto 70,53,200 Equity Shares face value of Rs.10.00 each for cash at a price of Rs. [●] per Equity Share of our Company aggregating to Rs. [●] Lakhs."}, {"bbox": [810, 2172, 840, 2199], "category": "Page-footer", "text": "52"}]